BioSpace News Archive

While individuals with osteoarthritis (OA) who undergo joint replacement surgery often experience reductions in pain, emotional distress and improved function, there is little known about how these recovery-related changes impact their spouse or marital relationship.

President Trump disclosed that he was taking hydroxychloroquine to protect himself against COVID-19—with the approval of his physicians.

Cigna and MultiCare Health System have reached a multi-year agreement that ensures access to quality care for Cigna customers at predictable, affordable rates.

Washington DC veterinary hospital, Friendship Hospital for Animals to merge with Encore Vet Group.

Hoag Family Cancer Institute and Pickup Family Neurosciences Institute at Hoag, in collaboration with Nascent Biotech, Inc announced today a first in the nation clinical trial for a novel immunotherapy treatment that holds considerable promise for glioblastoma (GBM), the deadliest form of brain cancer.

VitaLink Research, a leading multi-therapeutic clinical trial network, has adopted the leading, fully-integrated eSource, eRegulatory and Clinical Trial Management System (CTMS) from Clinical Research IO (CRIO).

Asklepios BioPharmaceutical , Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced the appointment of Tim Trost as Chief Financial Officer. Mr. Trost is a highly accomplished CFO with more than 25 years of experience building, managing and financing emerging life sciences companies. Prior to joining AskBio, Mr. Trost most recently served as CFO at Chimerix (NASDAQ: CMRX), w

Review highlights the history, progress and potential of cells of the innate immune system that can be harnessed for treatment of cancer

FDA-registered Clyraguard by Clyra Medical Technologies is a disinfecting personal protection spray for use on personal protection equipment (PPE), e.g. facemasks. The product has also been extensively tested and found to be safe for skin. TAMPA, FL, May 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Clyra Medical Technologies, Inc., today announced that it has received test results showing that its proprietary copper iodine antimicrobial and antiviral product, Clyraguard™, successfully i

New medicine one of several limited distribution drugs available through specialty pharmacy